Abstract
Galactosemia is one of a handful of inborn errors of metabolism for which newborns are tested in many states. The disorder results from the defective function of galactokinase, galactose 1-phosphate uridyltransferase, or uridine diphosphate galactose-4-epimerase. Treatment of galactosemia is best instituted during the first week of life and involves restriction of dietary galactose. This research was supported, in part, by Alabama Agricultural Experiment Station projects 13003 and 13006. Use of company or product name does not imply approval or recommendation of the product by Auburn University or the US Department of Agriculture, Agricultural Research Service, to the exclusion of others that may also be suitable. The authors acknowledge the technical contribution of J. Norman Livsey.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
